SEC 13F Intelligence

Roundangle Advisors LLC / OCUL

Roundangle Advisors LLC’s Ocular Therapeutix Inc Position

Does Roundangle Advisors LLC own Ocular Therapeutix Inc (OCUL)? Yes — 166.5K shares worth $1M (+1.05% of its 13F portfolio) as of Q1 2026, down from 168.9K shares the prior filed quarter.

Position Value
$1M
Q1 2026
Shares
166.5K
% of Portfolio
+1.05%
Quarters Held
6
currently held

Position History OCUL

Reported value by quarter
Q4 ’24: $2MQ4 ’24Q1 ’25: $1MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $2MQ4 ’25Q1 ’26: $1MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026166.5K$1M+1.05%
Q4 2025168.9K$2M+1.49%
Q3 2025176.8K$2M+1.60%
Q2 2025185.7K$2M+1.44%
Q1 2025195.9K$1M+1.32%
Q4 2024198.5K$2M+1.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Roundangle Advisors LLC’s full portfolio or all institutional holders of OCUL.